Keymed Biosciences
Biotechnology company developing antibody therapies for autoimmune disease and oncology.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Not Yet Recruiting · Atopic Dermatitis
Study of CM559 in Healthy SubjectsPhase 1 · Recruiting · Healthy Subjects
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain AmyloidosisPhase 2 · Recruiting · Primary Light-Chain Amyloidosis
Study of CM383 in Healthy SubjectsPhase 1 · Recruiting · Healthy
Study of CM512 in Patients With Moderate-to-Severe Atopic DermatitisPhase 2 · Recruiting · Atopic Dermatitis
Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)Phase 2 · Recruiting · Chronic Spontaneous Urticaria (CSU)
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/keymed-biosciences/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.